- Sunitinib, sold
under the
brand name
Sutent, is an anti-cancer medication. It is a small-molecule, multi-targeted
receptor tyrosine kinase (RTK) inhibitor...
- and had one
kidney removed in 2007,
doctors recommended he take the drug
Sutent.
Manchester Primary Care NHS
Trust refused to fund the £3,500 per month...
- of
everolimus in
carcinoid tumors have not been established.
sunitinib (
Sutent) is
labeled for
treatment of progressive, well-differentiated pancreatic...
-
several programs were
transferred to Pfizer.
These included sunitinib (
Sutent), a
cancer medication which was
approved for
human use by the FDA in January...
-
retrieved 29
September 2015. "
Sutent website".
Sutent.com.
Retrieved 16
January 2012. "FDA news
announcement on
Sutent". Fda.gov. 26
January 2006. Retrieved...
-
carcinoid tumors.
Targeted therapy with
everolimus (Afinitor) and
sunitinib (
Sutent) is
approved by the FDA in unresectable,
locally advanced or metastatic...
- 2003,
after developing the
pioneering kinase inhibitor drug
sunitinib (
Sutent).
Sugen was
founded in 1991 in
Redwood City, California, by
veteran biotech...
- with Parkinson's disease.
Examples of "promiscuous"
cancer drugs include:
Sutent, Sorafenib, Zactima, and AG-013736.[citation needed] In the
field of drugs...
- has
replaced gefitinib in this setting.
Sorafenib (Nexavar)
Sunitinib (
Sutent)
Dasatinib (Sprycel)
Lapatinib (Tykerb)
Nilotinib (Tasigna)
Bosutinib (Bosulif)...
- encountered, the multiple-tyrosine-kinase
inhibitor sunitinib (marketed as
Sutent) can be considered.: 26 and 31 The
effectiveness of
imatinib and sunitinib...
